NL170420C - Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat. - Google Patents

Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat.

Info

Publication number
NL170420C
NL170420C NLAANVRAGE7612364,A NL7612364A NL170420C NL 170420 C NL170420 C NL 170420C NL 7612364 A NL7612364 A NL 7612364A NL 170420 C NL170420 C NL 170420C
Authority
NL
Netherlands
Prior art keywords
corticoid
preparation
preparing
steroids
steroid containing
Prior art date
Application number
NLAANVRAGE7612364,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7612364A (nl
NL170420B (nl
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL7612364A publication Critical patent/NL7612364A/xx
Publication of NL170420B publication Critical patent/NL170420B/xx
Application granted granted Critical
Publication of NL170420C publication Critical patent/NL170420C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Electric Clocks (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7612364,A 1975-11-17 1976-11-08 Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat. NL170420C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/632,671 US4041055A (en) 1975-11-17 1975-11-17 Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes

Publications (3)

Publication Number Publication Date
NL7612364A NL7612364A (nl) 1977-05-20
NL170420B NL170420B (nl) 1982-06-01
NL170420C true NL170420C (nl) 1982-11-01

Family

ID=24536447

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7612364,A NL170420C (nl) 1975-11-17 1976-11-08 Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat.

Country Status (12)

Country Link
US (1) US4041055A (fr)
JP (3) JPS5262265A (fr)
CH (2) CH636362A5 (fr)
DE (1) DE2649753C2 (fr)
FR (2) FR2351997A1 (fr)
GB (4) GB1531048A (fr)
HU (8) HU178129B (fr)
IE (1) IE44548B1 (fr)
IL (3) IL50787A (fr)
MX (1) MX4328E (fr)
NL (1) NL170420C (fr)
PL (3) PL119050B1 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
US4216159A (en) * 1978-05-25 1980-08-05 The Upjohn Company Synthesis of 16-unsaturated pregnanes from 17-keto steroids
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
FR2486947A1 (fr) * 1980-07-15 1982-01-22 Roussel Uclaf Nouveaux derives steroides 20-isonitriles 17(20) insatures, leur procede de preparation et leur application a la preparation des steroides 17a-hydroxy 20-ceto
HU183397B (en) * 1981-04-16 1984-04-28 Richter Gedeon Vegyeszet Process for preparing 17alpha-hydroxy-pregn-4-ene-3,20-dione derivatives
US4412955A (en) * 1981-05-18 1983-11-01 The Upjohn Company Preparation of corticoids from 17-keto steroids
US4411835A (en) * 1981-05-18 1983-10-25 The Upjohn Company Preparation of corticoids from 17-keto steroids
US4357279A (en) * 1981-05-18 1982-11-02 The Upjohn Company Preparation of corticoids from 17-keto steroids
US4404142A (en) * 1981-05-18 1983-09-13 The Upjohn Company Preparation of corticoids from 17-keto steroids
US4342702A (en) * 1981-05-18 1982-08-03 The Upjohn Company Metallated halogenated acetylene corticoid synthesis
US4401599A (en) * 1981-05-18 1983-08-30 The Upjohn Company Preparation of 21-halo steroids
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
US4524134A (en) * 1982-07-30 1985-06-18 The Upjohn Company Process for preparing 1,2-dehydro steroids
DE3322120A1 (de) * 1982-07-30 1984-02-02 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur umwandlung von 1,2-gesaettigten 3-ketosteroiden in 1,2-dehydrosteroide
EP0104054A3 (fr) * 1982-09-20 1985-10-09 The Upjohn Company 16-Méthylène stéroides et leur préparation
US4704358A (en) * 1982-10-25 1987-11-03 The Upjohn Company Δ1 -dehydrogenation with heat or air-dried B. cyclooxidans
US4684610A (en) * 1983-03-15 1987-08-04 The Upjohn Company Process for converting 1,2-saturated steroids to 1,2-dehydro steroids
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
US4618456A (en) * 1984-03-20 1986-10-21 The Upjohn Company Ethynylation of 16-methyl-17-keto steroids
US4614621A (en) * 1984-04-20 1986-09-30 The Upjohn Company Ethynylation of 16-methylene-17-keto steroids
US4548748A (en) * 1984-02-03 1985-10-22 The Upjohn Company Cyanohydrin process
US4500461A (en) * 1984-02-03 1985-02-19 The Upjohn Company Cyanohydrin process
US4831131A (en) * 1984-02-03 1989-05-16 The Upjohn Company 11β,17α-Dihydroxy-17β-cyano-androstanes
US4585590A (en) * 1984-02-03 1986-04-29 The Upjohn Company Cyanohydrin process
US4530795A (en) * 1984-02-27 1985-07-23 The Upjohn Company Process for preparation of 16 α-methyl corticoids from Δ16 -steroids
US4600538A (en) * 1984-08-02 1986-07-15 The Upjohn Company Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes
US4613463A (en) * 1984-11-01 1986-09-23 The Upjohn Company Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
DE69132048T2 (de) * 1990-06-11 2000-07-13 Alcon Lab Inc N D Ges D Staate Verwendung von Steroiden zur Inhibierung von Angiogenesis
CA2425849C (fr) * 1991-11-22 2007-02-27 Alcon Laboratories, Inc. Steroides angiostatiques
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
HU227112B1 (hu) * 2006-06-14 2010-07-28 Richter Gedeon Nyrt Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz
DK2444092T3 (en) * 2008-05-28 2015-09-28 Reveragen Biopharma Inc Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease
WO2011127048A2 (fr) 2010-04-05 2011-10-13 Validus Biopharma MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES
CN102477060B (zh) * 2010-11-22 2014-08-13 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
JP6100798B2 (ja) 2011-12-23 2017-03-22 クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． １６−置換型−１７−ケトステロイド類のアルキニル化方法
CN106046099B (zh) * 2012-01-19 2018-03-16 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN104628806A (zh) * 2012-01-19 2015-05-20 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN102702296B (zh) * 2012-06-19 2014-09-03 山东诚创医药技术开发有限公司 环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法
CN102942612A (zh) * 2012-10-30 2013-02-27 四川大学 一种合成醋酸乌利司他的新方法
WO2014067127A1 (fr) * 2012-11-02 2014-05-08 Huang Yunsheng Procédé de synthèse de 6-méthyle-17α-acétoxy-19-noprégna-4,6-diène-3,20-dione
CN103145788B (zh) * 2013-03-25 2015-08-19 浙江仙琚制药股份有限公司 醋酸优力司特关键中间体的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN105001294A (zh) * 2015-07-29 2015-10-28 宝鸡康乐生物科技有限公司 一种妊娠素的合成方法
CN105153261B (zh) * 2015-10-08 2017-12-05 浙江仙居君业药业有限公司 一种炔孕酮的合成方法
CN106986908B (zh) * 2017-03-23 2019-05-10 湖南玉新药业有限公司 倍他米松的制备方法
CN106986911B (zh) * 2017-03-23 2019-05-10 湖南玉新药业有限公司 地塞米松关键中间体联烯亚砜物的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
CN112175035A (zh) * 2020-09-08 2021-01-05 山东斯瑞药业有限公司 一种倍他米松重排物的制备方法及倍他米松重排物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
US3499013A (en) * 1968-11-04 1970-03-03 Searle & Co 3-oxygenated 21beta-hydrocarbonsulfonyl-pregna-17(20),20-dienes,dehydro and 19-nor derivatives thereof and intermediates thereto
FR2150216A1 (en) * 1971-08-20 1973-04-06 Syntex Corp 17-vinylidene steroids - inters for progesterone derivs
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes

Also Published As

Publication number Publication date
FR2351997B1 (fr) 1980-11-14
IL50787A0 (en) 1976-12-31
DE2649753C2 (de) 1982-08-19
DE2649753A1 (de) 1977-05-26
CH636362A5 (de) 1983-05-31
PL116356B1 (en) 1981-06-30
HU188066B (en) 1986-03-28
GB1531050A (en) 1978-11-01
US4041055A (en) 1977-08-09
PL116459B1 (en) 1981-06-30
PL119050B1 (en) 1981-11-30
JPS5262265A (en) 1977-05-23
HU173670B (hu) 1979-07-28
NL7612364A (nl) 1977-05-20
IL58540A0 (en) 1980-01-31
JPH0113718B2 (fr) 1989-03-07
IE44548L (en) 1977-05-17
HU177914B (en) 1982-01-28
HU178128B (en) 1982-03-28
JPS6354393A (ja) 1988-03-08
IE44548B1 (en) 1981-12-30
GB1531047A (en) 1978-11-01
HU178129B (en) 1982-03-28
JPS6354391A (ja) 1988-03-08
PL215854A1 (fr) 1980-04-21
JPH0113719B2 (fr) 1989-03-07
JPS6228158B2 (fr) 1987-06-18
HU173541B (hu) 1979-06-28
PL214253A1 (fr) 1980-01-14
GB1531049A (en) 1978-11-01
GB1531048A (en) 1978-11-01
HU174396B (hu) 1979-12-28
PL193723A1 (fr) 1980-01-28
IL58539A0 (en) 1980-01-31
MX4328E (es) 1982-03-25
NL170420B (nl) 1982-06-01
HU188067B (en) 1986-03-28
FR2366310A1 (fr) 1978-04-28
IL50787A (en) 1983-06-15
CH630394A5 (de) 1982-06-15
FR2351997A1 (fr) 1977-12-16
FR2366310B1 (fr) 1980-11-14

Similar Documents

Publication Publication Date Title
NL170420C (nl) Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat.
NL7612173A (nl) Werkwijze voor het bereiden van een cholesterol- absorptieinhibiterend preparaat.
NL169751C (nl) Werkwijze voor het bereiden van een losmiddel.
NL190313C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met retard-effect.
NL7606179A (nl) Werkwijze voor de bereiding van een farmacolo- gisch actief heteroarylderivaat.
NL7613791A (nl) Werkwijze voor de bereiding van polyhalogeen- steroiden.
NL176863C (nl) Werkwijze voor het bereiden van een fijnverdeeld kiezelzuur.
NL7607902A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat.
NL7704245A (nl) Werkwijze voor het bereiden van een steroide.
NL7606824A (nl) Werkwijze voor het bereiden van een oraal preparaat.
NL7605322A (nl) Werkwijze voor het bereiden van een therapeutisch preparaat.
NL7604777A (nl) Werkwijze voor het bereiden van een weefselver- frissend preparaat.
NL187267C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat, alsmede werkwijze voor het bereiden van een n-aryl-n-(4-piperidinyl)aceetamide derivaat.
NL7706619A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat.
NL7605226A (nl) Werkwijze voor de bereiding van cardenolide ver- bindingen alsmede werkwijze voor de bereiding van een geneesmidel onder toepassing van deze verbin- dingen.
NL7604070A (nl) Werkwijze voor het bereiden van cardenolide- -glycosiden.
NL7606350A (nl) Werkwijze voor het bereiden van steroidecarbon- zuurlactonen.
NL7601423A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL172549C (nl) Werkwijze voor de bereiding van deltaÿ4-3-oxo-1alfa-methylsteroiden en gevormd geneesmiddel dat een aldus verkregen steroide bevat.
NL7614015A (nl) Werkwijze voor het bereiden van een farmaceu- tisch preparaat.
NL7600045A (nl) Werkwijze voor het bereiden van farmaceutische preparaten.
NL184724C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat dat een corticoide bevat.
NL7502319A (nl) Werkwijze voor de bereiding van een nieuw steroide.
NL7608480A (nl) Werkwijze voor het bereiden van een oraal prepa- raat.
NL186867C (nl) Werkwijze voor het bereiden van een thienamycineverbinding en voor het bereiden van farmaceutische preparaten.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 961108